Business News • MarketWire • AtheroNova Addresses Study Indicating Millions of Patients With Obstructive Sleep Apnea Prone to Aggressive Atherosclerosis

AtheroNova Addresses Study Indicating Millions of Patients With Obstructive Sleep Apnea Prone to Aggressive Atherosclerosis

AtheroNova Addresses Study Indicating Millions of Patients With Obstructive Sleep Apnea Prone to Aggressive Atherosclerosis

IRVINE, CA--(Marketwire - December 22, 2010) - AtheroNova Inc. (OTCBB: AHRO) ("AtheroNova"), a biotech company focused on the research and development of compounds to regress atherosclerotic plaque, commented on a study presented at the annual meeting of the Radiological Society of North America (RSNA) using CT angiography indicating that obese patients with Obstructive Sleep Apnea (OSA) were prone to an aggressive form of atherosclerosis characterized by increased amounts of soft plaque deposits in coronary arteries.

View More : http://www.marketwire.com/mw/release.do?id=1372868&sourceType=3

Releted News by marketwire

Wednesday Morning Tips: Bank of America, Citigroup Inc., JP Morgan Chase & Co., Visa Inc., Pfizer Inc., General Electric Co., Ford Motor Co., dPollution International Inc.

Regional Banking Sector Becomes a Hotbed of Merger and Acquisition Speculation